SeaStar Medical Holding (ICU) Receivables - Other (2021 - 2023)

SeaStar Medical Holding's (ICU) quarterly Receivables - Other came in at $100000.0 in Q3 2023, down 33.33% on a QoQ basis from $150000.0 in Q2 2023.

SeaStar Medical Holding (ICU) Receivables - Other (2021 - 2023) Analysis & Trends

SeaStar Medical Holding (ICU) has 3 years of Receivables - Other data on file, last reported at $100000.0 in Q3 2023.

Quarterly Receivables - Other changed N/A year-over-year to $100000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was -$4000.0 (down 102.67% YoY) and the FY2023 annual result came in at $200000.0, up 1566.67% from the prior year.
Receivables - Other slipped to $100000.0 in Q3 2023, from $150000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $200000.0 in Q1 2023 to a low of -$4000.0 in Q4 2022.
A 3-year average of $100800.0 and a median of $100000.0 in 2023 frame the typical range for Receivables - Other.
The widest YoY moves for Receivables - Other: up 106.9% in 2022, down 106.9% in 2022.
Tracing ICU's Receivables - Other over 3 years: stood at $58000.0 in 2021, then sank by 106.9% to -$4000.0 in 2022, then surged by 2600.0% to $100000.0 in 2023.
The last three Receivables - Other figures came in at $100000.0 (Q3 2023), $150000.0 (Q2 2023), and $200000.0 (Q1 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.09 Bn	131.23 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.66 Bn	77.66 Bn	3.93 Bn
3	Argenx Se	64.86 Bn	59.67 Bn	1.37 Bn
4	Moderna	58.07 Bn	52.93 Bn	52.00 Mn
5	BeOne Medicines	41.87 Bn	36.77 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.45 Bn	28.15 Bn	992.69 Mn
7	BioNTech SE	27.90 Bn	9.51 Bn	668.28 Mn
8	Insmed	27.40 Bn	26.24 Bn	358.27 Mn
9	Royalty Pharma	27.28 Bn	26.45 Bn	-
10	SeaStar Medical Holding	13.68 Mn	6.68 Mn	561,000.00

Download Data